subject area of
- Activation of factor X and prothrombin in antithrombin-III depleted plasma: The effects of heparin Journal Articles
- Age‐related changes in factor VII proteolysis in vivo Journal Articles
- Anticoagulant Actions of Tissue Factor Pathway Inhibitor on Tissue-Factor-Dependent Plasma Coagulation Journal Articles
- Anticoagulant Effect at the Time of Epidural Catheter Removal in Patients Receiving Twice-daily or Once-daily Low-molecular-weight Heparin and Continuous Epidural Analgesia after Orthopedic Surgery Journal Articles
- Comparison of 5-mg and 10-mg Loading Doses in Initiation of Warfarin Therapy Journal Articles
- Comparison of three‐factor and four‐factor prothrombin complex concentrates regarding reversal of the anticoagulant effects of rivaroxaban in healthy volunteers Journal Articles
- Discordance between the anti-Xa activity and the antithrombotic activity of an ultra-low molecular weight heparin fraction Journal Articles
- Effects of Fondaparinux on Mortality and Reinfarction in Patients With Acute ST-Segment Elevation Myocardial Infarction: The OASIS-6 Randomized Trial Journal Articles
- Effects of heparin fractions of different affinities to antithrombin III and thrombin on the inactivation of thrombin and factor Xa by antithrombin III Journal Articles
- Efficacy and safety of fondaparinux in patients with ST-segment elevation myocardial infarction across the age spectrum. Results from the Organization for the Assessment of Strategies for Ischemic Syndromes 6 (OASIS-6) trial Journal Articles
- Encapsulation of various recombinant mammalian cell types in different alginate microcapsules Journal Articles
- Fondaparinux versus Enoxaparin in non–ST-elevation acute coronary syndromes: Short-term cost and long-term cost-effectiveness using data from the Fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators (OASIS-5) trial Journal Articles
- Fondaparinux with UnfracTionated heparin dUring Revascularization in Acute coronary syndromes (FUTURA/OASIS 8): A randomized trial of intravenous unfractionated heparin during percutaneous coronary intervention in patients with non–ST-segment elevation acute coronary syndromes initially treated with fondaparinux Journal Articles
- Four-Factor Prothrombin Complex Concentrate for Urgent Reversal of Vitamin K Antagonists in Patients With Major Bleeding Journal Articles
- Four-factor Prothrombin Complex Concentrate for the Management of Patients Receiving Direct Oral Activated Factor X Inhibitors Journal Articles
- Heparan sulfate and dermatan sulfate inhibit the generation of thrombin activity in plasma by complementary pathways Journal Articles
- Heparan sulfate and dermatan sulfate inhibit the generation of thrombin activity in plasma by complementary pathways. Journal Articles
- Heparin Cofactor II and Other Endogenous Factors in the Mediation of the Antithrombotic and Anticoagulant Effects of Heparin and Dermatan Sulfate Journal Articles
- Heparin with low affinity to antithrombin III inhibits the activation of prothrombin in normal plasma Journal Articles
- Heparin‐induced thrombocytopenia and thrombosis: clinical and laboratory studies Journal Articles
- INVIVO EFFECTS OF LOW-MOLECULAR-WEIGHT HEPARINS ON EXPERIMENTAL THROMBOSIS AND BLEEDING Journal Articles
- Identification of a Unique Glomerular Factor X Activator in Murine Lupus Nephritis Journal Articles
- Idrabiotaparinux treatment for venous thromboembolism Journal Articles
- Immunologic Identification of the Cleavage Products from the Aα- and Bβ-Chains in the Early Stages of Plasmin Digestion of Fibrinogen Journal Articles
- In vivo Effects of Low Molecular Weight Heparins on Experimental Thrombosis and Bleeding Journal Articles
- Inhibition of factor X and factor V activation by dermatan sulfate and a pentasaccharide with high affinity for antithrombin III in human plasma Journal Articles
- Inhibition of factor X, factor V and prothrombin activation by the bis(lactobionic acid amide) LW10082 Journal Articles
- Inhibition of the amplification reactions of blood coagulation by site-specific inhibitors of α-thrombin Journal Articles
- Linkage analysis for three coagulation factors clustering on chromosome 13q34: factor VII, factor X and protein Z Journal Articles
- Mechanisms for the Anticoagulant Effects of Synthetic Antithrombins Journal Articles
- Modulation of intrinsic prothrombin activation by fibrinogen and fibrin I. Journal Articles
- Placental Barrier to Coagulation Factors: Its Relevance to the Coagulation Defect at Birth and to Haemorrhage in the Newborn Journal Articles
- Rationale Behind the Development of Low Molecular Weight Heparin Derivatives Journal Articles
- Suboptimal effect of a three‐factor prothrombin complex concentrate (Profilnine‐SD) in correcting supratherapeutic international normalized ratio due to warfarin overdose Journal Articles
- The Editor's Roundtable: Arterial Thrombosis and Acute Coronary Syndromes Journal Articles
- The activation of coagulation by extracts of mucus: a possible pathway of intravascular coagulation accompanying adenocarcinomas. Journal Articles
- The affinity of human, rabbit and bovine thrombins for sepharose-lysine and other conjugates Journal Articles
- The factor VIII-independent activation of factor X by factors IXa and VII in plasma Journal Articles
- The haemorrhagic and antithrombotic effects of dermatan sulphate Journal Articles
- The haemorrhagic and antithrombotic effects of dermatan sulphate. Journal Articles
- The importance of thrombin inhibition for the expression of the anticoagulant activities of heparin, dermatan sulphate, low molecular weight heparin and pentosan polysulphate Journal Articles
- The inhibition by heparin of the intrinsic pathway activation of factor X in the absence of antithrombin-III Journal Articles
- The inhibition of the anticoagulant activity of heparin by platelets, brain phospholipids, and tissue factor Journal Articles
- The inhibition of thrombin-dependent positive-feedback reactions is critical to the expression of the anticoagulant effect of heparin Journal Articles
- The isolation of prothrombin, factor IX and factor X from human factor IX concentrates Journal Articles
- The relative importance of thrombin inhibition and factor Xa inhibition to the antithrombotic effects of heparin Journal Articles
- Venous thromboembolism management: where do novel anticoagulants fit? Journal Articles